Last updated: 2026-09-16 12:10:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cronos Group Inc. (CRON) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $3.18, with a market capitalisation of $1.19B and a P/E ratio of 16.85. Over the past 52 weeks, its price has ranged from $2.28 to $3.61. This page covers its latest market performance, valuation, price trends and company information.
$1.19B | |
$3.17 | |
$25.10 | |
$1.60 | |
$3.20 | |
51.00 | |
1.15M | |
16.85 | |
$3.61 | |
$2.28 | |
0.53% | |
-- |
Cronos Group Inc. (CRON) is trading at $3.18 in pre-market trading as of 2026-09-16 11:46:00, down 0.78% ($0.03) from the previous close of $3.20
Pre-market trading shows how investors are pricing CRON before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Cronos Group Inc. (CRON) moved from $3.26 to $3.18, representing a decline of 2.61% ($0.08).
The stock traded between $3.09 and $3.27 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 689.96 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 67.4%
CRON is currently trading at $3.18, placing it 67.4% of the way from its 52-week low of $2.28 to its 52-week high of $3.61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 610 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cronos Group Inc. (CRON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.